marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Neurocrine Biosciences Financial Ratios 2011-2024 | NBIX
Annual Financial Ratios Neurocrine Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
51.7 | 64.4 | 83.4 | 25.1 | 251.2 | 372.8 | -53.8 | -24.7 | -40.4 | -41.5 | -24.9 | 114.9 | 13.6 |
P/S |
6.8 | 6.7 | 6.6 | 9.8 | 11.8 | 17.4 | 47.4 | 232.0 | 181.9 | - | 392.9 | 10.9 | 6.6 |
EPS |
2.6 | 1.6 | 0.9 | 4.4 | 0.4 | 0.2 | -1.6 | -1.6 | -1.1 | -0.8 | -0.7 | 0.1 | 0.7 |
EV (Enterprise Value) |
13.7 B | 10.3 B | 7.83 B | 10.6 B | 9.86 B | 8.24 B | 7.86 B | 3.45 B | 3.57 B | 2.51 B | 1.14 B | 555 M | 537 M |
EBITDA per Share |
2.75 | 2.76 | 1.2 | 1.84 | 2.55 | 0.453 | -1.46 | -1.68 | -1.1 | -0.853 | -0.732 | 0.0321 | 0.627 |
EV/EBITDA |
69.1 | 29.3 | 41.0 | 198.4 | -60.3 | -23.3 | -37.8 | -39.0 | -22.5 | 244.0 | 13.3 | ||
PEG |
0.49 | 0.81 | 1.63 | 0.36 | 3.4 | 3.26 | -87.68 | 0.45 | 1.36 | 2.38 | 0.02 | -1.29 | 0.02 |
P/B |
5.8 | 5.8 | 5.4 | 9.1 | 14.6 | 16.4 | 20.6 | 11.1 | 8.5 | 12.0 | 9.5 | 3.7 | 8.5 |
P/CF |
33.1 | 29.3 | 29.1 | 44.7 | 67.7 | 102.8 | -75.7 | -31.6 | -90.0 | -51.5 | -38.0 | -15.9 | -355.9 |
ROE % |
11.19 | 9.05 | 6.52 | 36.17 | 5.81 | 4.39 | -38.30 | -44.81 | -20.95 | -29.01 | -38.28 | 3.26 | 62.53 |
ROA % |
7.68 | 6.52 | 4.32 | 23.48 | 2.83 | 2.13 | -17.43 | -38.65 | -18.73 | -24.91 | -29.80 | 2.56 | 27.15 |
ROCE % |
11.24 | 14.58 | 7.46 | 14.47 | 30.58 | 4.08 | -17.21 | -44.03 | -20.98 | -28.33 | -34.75 | 0.80 | 37.17 |
Current Ratio |
3.2 | 3.6 | 3.0 | 2.9 | 1.5 | 8.4 | 10.2 | 10.2 | 14.9 | 12.7 | 12.7 | 12.1 | 2.8 |
DSO |
76.3 | 65.6 | 55.2 | 49.5 | 58.6 | 45.5 | 70.3 | - | - | - | 2.9 | 96.8 | 9.0 |
DIO |
337.4 | 516.0 | 746.6 | 818.3 | 849.5 | 811.1 | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 2270.9 | 1030.3 | 1644.0 | - | - | - | - | - | - |
Operating Cycle |
413.8 | 581.7 | 801.8 | 867.8 | 908.1 | 856.6 | 70.3 | - | - | - | - | - | - |
Cash Conversion Cycle |
413.8 | 581.7 | 801.8 | 867.8 | -1362.8 | -173.8 | -1573.7 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Neurocrine Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.28 | 0.64 | 0.43 | - | 0.85 | 0.98 | -0.79 | - | 0.72 | -0.18 | 0.15 | - | 0.24 | 0.45 | 0.34 | 3.72 | -0.62 | 0.86 | 0.4 | 0.37 | 0.59 | 0.56 | -1.12 | 0.2 | 0.56 | -0.07 | -0.47 | 0.08 | -0.13 | -0.68 | -0.9 | -0.51 | -0.43 | -0.46 | -0.22 | -0.34 | -0.4 | -0.28 | -0.01 | -0.26 | -0.21 | -0.18 | -0.17 | -0.16 | -0.17 | -0.18 | -0.18 | 0.14 | -0.05 | -0.01 | -0.01 | 0.02 | 0.57 | 0.04 | 0.05 |
EBITDA per Share |
- | - | 1.05 | - | - | - | -1.13 | - | 1.03 | 0.57 | 0.07 | - | 0.55 | 0.66 | 0.36 | - | -0.41 | 0.87 | 0.66 | - | 1.04 | 0.41 | -1.09 | - | 0.63 | - | -0.41 | - | -0.05 | -0.64 | -0.91 | - | -0.43 | -0.48 | -0.24 | - | -0.41 | -0.29 | -0.03 | - | -0.21 | -0.18 | -0.18 | - | -0.17 | -0.19 | -0.19 | - | -0.05 | -0.02 | -0.03 | - | 0.56 | 0.03 | 0.04 |
ROE % |
13.33 | 12.71 | 15.27 | 4.76 | 9.19 | 9.48 | 3.13 | 4.25 | 5.92 | 3.16 | 7.65 | 7.64 | 38.53 | 31.75 | 35.51 | 36.17 | 10.61 | 24.17 | 25.16 | 5.81 | 4.23 | 6.34 | -2.94 | 4.39 | 2.48 | -11.07 | -25.95 | -38.30 | -54.34 | -63.06 | -59.74 | -44.81 | -37.53 | -33.93 | -26.79 | -20.95 | -23.36 | -22.86 | -23.62 | -29.01 | -28.53 | -30.17 | -33.92 | -38.28 | -23.29 | -16.04 | -6.20 | 3.26 | -0.68 | 53.55 | 57.16 | 62.53 | 52.23 | 3.29 | 4.80 |
ROA % |
9.81 | 9.05 | 10.74 | 3.33 | 6.52 | 6.80 | 3.79 | 4.49 | 5.61 | 2.88 | 5.04 | 5.02 | 25.07 | 20.64 | 23.06 | 23.48 | 6.03 | 13.47 | 12.81 | 2.83 | 2.05 | 3.04 | -1.48 | 2.13 | 1.15 | -5.32 | -12.06 | -17.43 | -30.51 | -39.25 | -42.95 | -38.65 | -32.59 | -29.74 | -23.76 | -18.73 | -20.56 | -19.84 | -20.29 | -24.91 | -23.79 | -24.45 | -26.86 | -29.80 | -18.08 | -12.45 | -4.79 | 2.56 | -1.32 | 22.93 | 24.62 | 27.15 | 22.68 | 1.43 | 2.08 |
ROCE % |
23.77 | 24.06 | 22.24 | 4.25 | 9.93 | 8.56 | 8.43 | 9.75 | 13.06 | 10.68 | 11.74 | 10.83 | 6.89 | -0.35 | 1.55 | 8.10 | 22.24 | 40.32 | 38.92 | 3.69 | 14.99 | 12.14 | 6.36 | 3.13 | 1.51 | -11.40 | -26.40 | -38.48 | -50.69 | -61.28 | -59.18 | -32.11 | -40.56 | -36.80 | -29.48 | -14.95 | -23.03 | -22.66 | -23.57 | -21.06 | -31.03 | -32.92 | -36.97 | -31.68 | -34.25 | -26.84 | -16.80 | -4.62 | 46.04 | 99.28 | 101.99 | 55.72 | 50.66 | 1.82 | 3.23 |
Current Ratio |
4.3 | 4.2 | 3.2 | 3.2 | 3.4 | 3.4 | 3.5 | 3.6 | 3.6 | - | 2.9 | 3.0 | 3.0 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 7.3 | 7.3 | 7.3 | 7.3 | 9.4 | 9.4 | 9.4 | 9.4 | 7.1 | 7.1 | 7.1 | 7.1 | 4.5 | 4.5 | 4.5 | 4.5 | 4.7 | 4.7 | 4.7 | 4.7 | 1.8 | 1.8 | 1.8 | 1.8 |
DSO |
69.6 | 71.0 | 78.8 | - | 73.7 | 78.5 | 80.5 | - | 35.4 | 31.8 | 66.0 | - | 49.7 | 48.4 | 58.8 | 57.8 | 55.5 | 47.4 | 54.6 | 47.3 | 52.0 | 63.0 | 60.7 | 39.8 | 34.2 | 53.0 | 56.1 | 30.1 | 46.7 | 448.4 | - | - | - | - | 45.9 | - | - | - | 69.3 | - | - | - | - | 174.9 | 7.1 | 172.6 | 1050.8 | 58.6 | 137.4 | 121.6 | 64.8 | 15.6 | 4.2 | 14.3 | - |
DIO |
503.6 | 395.2 | 459.3 | - | 246.5 | 258.3 | 367.7 | - | 276.7 | 275.6 | 590.1 | - | 584.4 | 859.5 | 914.1 | - | 946.3 | 1064.6 | 984.2 | - | 717.6 | 986.6 | 1138.2 | - | 639.2 | 1160.8 | 570.9 | - | 121.4 | 95.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 557.7 | - | - | - | 271.2 | - | - | 637.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
573.2 | 466.3 | 538.1 | - | 320.1 | 336.8 | 448.2 | - | 312.2 | 307.4 | 656.1 | - | 634.1 | 907.9 | 972.9 | 57.8 | 1001.8 | 1112.0 | 1038.8 | 47.3 | 769.6 | 1049.6 | 1198.8 | 39.8 | 673.3 | 1213.8 | 627.0 | 30.1 | 168.1 | 544.1 | - | - | - | - | 45.9 | - | - | - | 69.3 | - | - | - | - | 174.9 | 7.1 | 172.6 | 1050.8 | 58.6 | 137.4 | 121.6 | 64.8 | 15.6 | 4.2 | 14.3 | - |
Cash Conversion Cycle |
573.2 | 466.3 | 538.1 | - | 320.1 | 336.8 | 448.2 | - | 312.2 | 307.4 | 656.1 | - | 634.1 | 907.9 | 972.9 | 57.8 | 1001.8 | 1112.0 | 1038.8 | 47.3 | 769.6 | 1049.6 | 641.1 | 39.8 | 673.3 | 1213.8 | 355.8 | 30.1 | 168.1 | -93.2 | - | - | - | - | 45.9 | - | - | - | 69.3 | - | - | - | - | 174.9 | 7.1 | 172.6 | 1050.8 | 58.6 | 137.4 | 121.6 | 64.8 | 15.6 | 4.2 | 14.3 | - |
All numbers in USD currency